Medscape

The Evolving Landscape of Sickle Cell Disease Treatment

Gene therapy and small molecules are opening the door to new curative approaches, but access continues to be a barrier for most patients.

SCD: Gets The Job Done But Not The Most Efficient Income Fund

LMP Capital & Income Fund's (SCD) 9.2% yield and distribution outlook: coverage, risk profile, and Franklin Templeton’s ...
The American Journal of Managed Care

Study: Patients With SCD Report Discrimination Based on Race, Pain, and Other Factors

A new report based on patient focus groups suggests many clinicians can do more to help patients with sickle cell disease (SCD) feel heard and understood. People with sickle cell disease (SCD) say a ...
The American Journal of Managed Care

SCD Birth Rate Higher in Socially Vulnerable Areas, Study Finds

A cross-sectional analysis assessed the birth prevalence of sickle cell disease (SCD) alongside data on social vulnerability to highlight the needs of communities impacted by SCD. SCD, a blood ...
Medscape

Week in the Life: Hematologist Juggles SCD’s Challenges

For classical hematologist Srila Gopal, MD, overseeing the care of about 250 adults with sickle cell disease (SCD) and thalassemia isn’t just a matter of diagnosis and treatment. In just a single week ...
Nature

Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models

Breast cancer brain metastases (BCBM) are incurable, and new therapies are urgently needed. BCBM upregulates stearoyl-CoA desaturase (SCD), an enzyme that catalyzes the synthesis of monounsaturated ...